Page last updated: 2024-08-17

mannitol and mart-1 antigen

mannitol has been researched along with mart-1 antigen in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Batard, P; Cerottini, JC; Guillaume, P; Liénard, D; Pittet, MJ; Rimoldi, D; Romero, P; Speiser, DE	1
Collins, S; Coventry, B; Farrelly, M; Hersey, P; Hirst, D; Johnson, H; Menzies, SW; Nguyen, T	1
Davis, T; Groshen, S; Keler, T; Lee, P; Liu, D; Nichol, G; Sanderson, K; Scotland, R; Sian, S; Snively, J; Weber, J; Yellin, M	1
Allred, JB; Celis, E; Creagan, ET; Ingle, JN; Kaur, JS; Loprinzi, CL; Markovic, SN; Nevala, WK; Pitot, HC; Pittelkow, MR; Rao, RD; Suman, VJ	1

Trials

2 trial(s) available for mannitol and mart-1 antigen

Article	Year
Phase I/II study of immunotherapy with T-cell peptide epitopes in patients with stage IV melanoma. Cancer immunology, immunotherapy : CII, 2005, Volume: 54, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antigens, Neoplasm; Cytokines; Enzyme-Linked Immunosorbent Assay; Epitopes; Epitopes, T-Lymphocyte; Female; gp100 Melanoma Antigen; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Hypersensitivity, Delayed; Immunity, Cellular; Immunotherapy; Inflammation; Interferon-gamma; Lymphocytes; Male; Mannitol; MART-1 Antigen; Melanoma; Membrane Glycoproteins; Middle Aged; Monophenol Monooxygenase; Neoplasm Proteins; Oleic Acids; Peptides; Skin Neoplasms; Time Factors; Treatment Outcome	2005
Peptide vaccination of patients with metastatic melanoma: improved clinical outcome in patients demonstrating effective immunization. American journal of clinical oncology, 2006, Volume: 29, Issue:4 Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Antigens, Neoplasm; Cancer Vaccines; Female; gp100 Melanoma Antigen; Granulocyte-Macrophage Colony-Stimulating Factor; HLA-A2 Antigen; Humans; Hypersensitivity, Delayed; Immunophenotyping; Male; Mannitol; MART-1 Antigen; Melanoma; Membrane Glycoproteins; Middle Aged; Monophenol Monooxygenase; Neoplasm Proteins; Oleic Acids; Recombinant Proteins; Skin Neoplasms; Survival Analysis; Vaccines, Subunit	2006

Article

Year

Phase I/II study of immunotherapy with T-cell peptide epitopes in patients with stage IV melanoma.

Cancer immunology, immunotherapy : CII, 2005, Volume: 54, Issue:3

Topics: Adult; Aged; Aged, 80 and over; Antigens, Neoplasm; Cytokines; Enzyme-Linked Immunosorbent Assay; Epitopes; Epitopes, T-Lymphocyte; Female; gp100 Melanoma Antigen; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Hypersensitivity, Delayed; Immunity, Cellular; Immunotherapy; Inflammation; Interferon-gamma; Lymphocytes; Male; Mannitol; MART-1 Antigen; Melanoma; Membrane Glycoproteins; Middle Aged; Monophenol Monooxygenase; Neoplasm Proteins; Oleic Acids; Peptides; Skin Neoplasms; Time Factors; Treatment Outcome

2005

Peptide vaccination of patients with metastatic melanoma: improved clinical outcome in patients demonstrating effective immunization.

American journal of clinical oncology, 2006, Volume: 29, Issue:4

Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Antigens, Neoplasm; Cancer Vaccines; Female; gp100 Melanoma Antigen; Granulocyte-Macrophage Colony-Stimulating Factor; HLA-A2 Antigen; Humans; Hypersensitivity, Delayed; Immunophenotyping; Male; Mannitol; MART-1 Antigen; Melanoma; Membrane Glycoproteins; Middle Aged; Monophenol Monooxygenase; Neoplasm Proteins; Oleic Acids; Recombinant Proteins; Skin Neoplasms; Survival Analysis; Vaccines, Subunit

2006

Other Studies

2 other study(ies) available for mannitol and mart-1 antigen

Article	Year
In vivo activation of melanoma-specific CD8(+) T cells by endogenous tumor antigen and peptide vaccines. A comparison to virus-specific T cells. European journal of immunology, 2002, Volume: 32, Issue:3 Topics: Adjuvants, Immunologic; Antigens, Neoplasm; Antigens, Viral; Cancer Vaccines; CD8-Positive T-Lymphocytes; Cell Differentiation; Cytomegalovirus; HLA-A2 Antigen; HLA-DR Antigens; Humans; Immunologic Memory; Immunotherapy; Influenza A virus; Lymphocyte Activation; Mannitol; MART-1 Antigen; Melanoma; Neoplasm Proteins; Oleic Acids; Peptide Fragments; Vaccines, Subunit; Viral Matrix Proteins	2002
Autoimmunity in a phase I trial of a fully human anti-cytotoxic T-lymphocyte antigen-4 monoclonal antibody with multiple melanoma peptides and Montanide ISA 51 for patients with resected stages III and IV melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Feb-01, Volume: 23, Issue:4 Topics: Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation; Antigens, Neoplasm; Autoimmunity; Cancer Vaccines; CTLA-4 Antigen; Female; Flow Cytometry; gp100 Melanoma Antigen; Humans; Male; Mannitol; MART-1 Antigen; Melanoma; Membrane Glycoproteins; Middle Aged; Monophenol Monooxygenase; Neoplasm Proteins; Neoplasm Staging; Oleic Acids; Peptide Fragments; Receptors, CCR; Receptors, Chemokine; Vaccination	2005

Article

Year

In vivo activation of melanoma-specific CD8(+) T cells by endogenous tumor antigen and peptide vaccines. A comparison to virus-specific T cells.

European journal of immunology, 2002, Volume: 32, Issue:3

Topics: Adjuvants, Immunologic; Antigens, Neoplasm; Antigens, Viral; Cancer Vaccines; CD8-Positive T-Lymphocytes; Cell Differentiation; Cytomegalovirus; HLA-A2 Antigen; HLA-DR Antigens; Humans; Immunologic Memory; Immunotherapy; Influenza A virus; Lymphocyte Activation; Mannitol; MART-1 Antigen; Melanoma; Neoplasm Proteins; Oleic Acids; Peptide Fragments; Vaccines, Subunit; Viral Matrix Proteins

2002

Autoimmunity in a phase I trial of a fully human anti-cytotoxic T-lymphocyte antigen-4 monoclonal antibody with multiple melanoma peptides and Montanide ISA 51 for patients with resected stages III and IV melanoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Feb-01, Volume: 23, Issue:4

Topics: Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation; Antigens, Neoplasm; Autoimmunity; Cancer Vaccines; CTLA-4 Antigen; Female; Flow Cytometry; gp100 Melanoma Antigen; Humans; Male; Mannitol; MART-1 Antigen; Melanoma; Membrane Glycoproteins; Middle Aged; Monophenol Monooxygenase; Neoplasm Proteins; Neoplasm Staging; Oleic Acids; Peptide Fragments; Receptors, CCR; Receptors, Chemokine; Vaccination

2005